AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Lauran Neergaard
Aug. 9--WASHINGTON--A cholesterol-lowering drug taken by 700,000 Americans -- Bayer Pharmaceutical's Baycol -- was pulled off the market Wednesday because of muscle destruction linked to 31 U.S. deaths and at least nine more fatalities abroad.
Baycol is one of a popular family of drugs called statins that dramatically lower cholesterol and reduce patients' risk of heart attacks. Yet every statin has been linked to very rare reports of the muscle side effect called rhabdomyolysis.
The millions of Americans who take any of five other statins sold in the United States should not panic, Food and Drug Administration physicians…